Loading chat...
OK HB1388
Bill
Status
Engrossed
3/10/2015
Primary Sponsor
Ann Griffin
Click for details
AI Summary
- Defines "opioid analgesic drug product" as a drug product in the opioid class prescribed to treat moderate to severe pain or other conditions in immediate release or extended release/long-acting form, whether combined with other substances or not
- Defines "abuse-deterrent opioid analgesic drug product" as a brand or generic opioid analgesic drug product approved by the FDA with abuse-deterrence labeling claims indicating meaningful reduction in abuse
- Defines "cost-sharing" as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense requirements
- Defines "health benefit plan" as any plan or arrangement as defined in subsection C of Section 6060.4 of Title 36 of the Oklahoma Statutes
- Becomes effective November 1, 2015
Legislative Description
Prescription drugs; defining terms; effective date.
Drugs
Last Action
Second Reading referred to Health and Human Services
3/18/2015
Committee Referrals
Health and Human Services3/18/2015
Alcohol, Tobacco, and Controlled Substances2/23/2015
Rules2/3/2015
Full Bill Text
No bill text available